* Public-private Global Fund fights AIDS, TB and malaria

* Donors due to meet in late 2013 to replenish funds

* Fund director says investment now will avert huge costs

By Kate Kelland

LONDON, Sept 12 (Reuters) - The world's biggest funder of the fight against AIDS, tuberculosis (TB) and malaria said on Thursday it needs $15 billion over the next three years to begin bringing "the three big global pandemics" under control.

In a report released ahead of a pledging conference later this year, the Global Fund to Fight AIDS, TB and Malaria said timely investments could avert $47 billion in extra treatment costs and save millions of lives, but warned that acting too late would mean missing important opportunities.

"The cost of inaction is far greater than the cost of action, from both a moral and an economic perspective," Joanne Carter, head of the RESULTS Educational Fund in the United States and a former Global Fund board member, told reporters.

"We are at the tipping point in the fight against HIV, TB and malaria. If we invest ambitiously now we can save millions of lives and literally defeat these diseases in our lifetime."

The public-private Global Fund, based in Geneva, accounts for around a quarter of international financing to fight HIV and AIDS, and the majority of global funds to fight TB and malaria.

Founded in 2002, the fund raises money from donors every three years and in 2010 secured just under $12 billion for the years 2011 to 2013.

According to the World Health Organisation, malaria infected some 219 million people in 2010, killing around 660,000 of them. Robust figures are, however, hard to establish and other health experts say the annual malaria death toll could be double that.

Some 34 million people were living with the human immunodeficiency virus (HIV) that causes AIDS at the end of 2011, while deaths from AIDS fell to 1.7 million that year from a peak of 2.3 million in 2005.

The Global Fund says that of the estimated 9 million cases of TB worldwide in 2012, only 6 million were diagnosed and treated - leaving an estimated 3 million people with TB who went undiagnosed, untreated or unreported.

International health experts say the tools, medicines and expertise already exist to be able to all but end these three infectious diseases, but say it is a battle to keep up funding levels in a tough global economic climate.

"There are three compelling factors that make this a unique opportunity to fight and defeat these diseases," said Mark Dybul, the Global Funds' executive director.

"We have the experience to know how to fight them effectively, we have new scientific tools, and we understand the epidemiology of these diseases better than ever. We can make a transformative difference, and if we do not act now, the costs will be staggering."

If international donors fail to stump up the at least $15 billion needed, Dybul said this could lead to millions of avoidable cases of HIV during the funding period of 2014 to 2016, which over these patients lifetimes would add up to $47 billion of treatment costs.

Some 3 million fewer people would be treated for TB, and a million lives would be unnecessarily lost because of that, he said, and in malaria the consequences of inadequate funding would be 196,000 lives lost per year and 430 million malaria cases that could have been prevented.

The lion's share of the funding for the Global Fund comes from OECD governments. Private sector entities such as the Bill and Melinda Gates Foundation and Coca-Cola also contribute financially and with services. (Editing by Sonya Hepinstall)




Loading Slideshow...



  • 1. Most Don't Have Their Infection Under Control


    Only one quarter of the 1.1 million <a href="http://www.cdc.gov/nchhstp/newsroom/docs/2012/Stages-of-CareFactSheet-508.pdf">people with HIV</a> have their <a href="http://www.huffingtonpost.com/2012/07/27/hiv-under-control-1-in-4_n_1711260.html">condition under control</a>, where "under control" means the virus has been suppressed, according to a report released this summer by the Centers for Disease Control and Prevention. "Only if we get <a href="http://www.philly.com/philly/health/HealthDay667108_20120727_Only_1_in_4_Americans_With_HIV_Has_Virus_Under_Control__CDC.html">everyone under regular care</a> for HIV/AIDS can we recognize the full benefits of treatment and prevention," Irene Hall, an epidemiologist at the CDC and one of the authors of the report, told HealthDay. <em><strong>CORRECTION</strong>: The first sentence has been reworded to more accurately reflect the number of people with HIV.</em>




  • 2. Bone Marrow Transplants Could Play A Part In Being HIV-Free


    Two men with HIV and cancer no longer have <a href="http://www.huffingtonpost.com/2012/07/26/hiv-free-men-bone-marrow-transplants_n_1707505.html">detectable blood levels of the virus</a> after receiving bone marrow transplants for their cancers, news outlets reported this year. Doctors were unable to <a href="http://www.huffingtonpost.com/2012/07/26/hiv-free-men-bone-marrow-transplants_n_1707505.html">find any traces of HIV</a> in the men's cells after they received the bone marrow transplants while also being treated with antiretrovirals. The finding "suggests that under the <a href="http://abcnews.go.com/blogs/health/2012/07/26/two-more-patients-hiv-free-after-bone-marrow-transplants/">cover of anti-retroviral therapy</a>, the cells that repopulated the patient's immune system appear to be protected from becoming re-infected with HIV," Dr. Timothy Henrich, of Brigham and Women's Hospital, told ABC News. However, the Boston Globe pointed out that it's still too soon to say that these men have been<a href="http://www.huffingtonpost.com/2012/07/26/hiv-free-men-bone-marrow-transplants_n_1707505.html"> full-on <em>cured</em></a> of HIV, since they are still on the anti-retrovirals. There's no firm word on whether they will go off of the medication.




  • 3. No-Cost HIV Treatment Could Cut New Infection Rates


    New <a href="http://www.huffingtonpost.ca/2012/11/27/free-hiv-drugs-decrease-infection-bc_n_2200393.html">HIV infection rates</a> can be dramatically lowered by making antiretroviral drugs free, a study from Canadian researchers found. The Canadian Press reported on the study, conducted by B.C. Centre for Excellence in HIV-AIDS researchers, which showed that British Columbia -- a province that offers <a href="http://www.huffingtonpost.ca/2012/11/27/free-hiv-drugs-decrease-infection-bc_n_2200393.html">free access to antiretroviral therapy</a> -- had the lowest rate of new HIV infections over a more-than-10-year period, compared with Ontairio and Quebec.




  • 4. Many Young People Don't Know Their HIV Status


    More than half of HIV-infected young people are <a href="http://www.huffingtonpost.com/2012/11/27/hiv-youths-infected-aids-young-people_n_2198629.html">unaware that they have the virus</a>, according to a Centers for Disease Control and Prevention report. "Given everything we know about HIV and how to prevent it in 30 years of fighting the disease, it's just unacceptable that young people are <a href="http://www.huffingtonpost.com/2012/11/27/hiv-youths-infected-aids-young-people_n_2198629.html">becoming infected at such high rates</a>," Reuters reported CDC Director Dr. Thomas Frieden saying. The report also showed that for young people, 72 percent of the new HIV infections were in men who have sex with men, while almost 50 percent were in young, African-American males, Reuters reported. These figures are based on 2010 data.




  • 5. More People Are Living With HIV Than 10 Years Ago


    The number of people <a href="http://www.huffingtonpost.com/2012/07/18/hiv-aids-numbers-statistics-worldwide_n_1682936.html">living with HIV</a> has increased by 18 percent from 2001 to 2011, according to a report released this year from the United Nations Programme on AIDS. An estimated 34.2 million people around the world are living with HIV. The report also showed that <a href="http://www.huffingtonpost.com/2012/07/18/hiv-aids-numbers-statistics-worldwide_n_1682936.html">deaths from AIDS </a>have <em>dropped</em>, from 2.3 million in 2005-2006 to 1.7 million in 2011, Reuters reported.




  • 6. The Cost Of HIV Drugs Is Decreasing


    According to the same United Nations report, costs for the cheapest UN-recommended <a href="http://www.huffingtonpost.com/2012/07/18/hiv-aids-numbers-statistics-worldwide_n_1682936.html">antiretroviral therapy drugs</a> have also decreased over the past 10 years, Reuters reported. A year's worth of the drugs used to cost $10,000 in 2000 for one person; now, it costs $100 a year.




  • 7. HIV Treatment Truvada Can Also Be Used As A Preventive Measure


    The Food and Drug Administration this year officially approved the <a href="http://www.huffingtonpost.com/2012/08/09/truvada-heterosexuals-aids-hiv-prevention-pill_n_1760542.html">drug Truvada</a> -- which has been used since 2004 as a treatment for HIV -- to be sold as a preventive measure for people who don't have the infection, but are at high risk for it. The FDA said that the pill should be considered for <a href="http://www.huffingtonpost.com/2012/08/09/truvada-heterosexuals-aids-hiv-prevention-pill_n_1760542.html">preventive use</a> not only by gay or bisexual men who are at high risk for HIV, but also heterosexual men and women who may also face HIV risks, the Associated Press reported. <a href="http://www.huffingtonpost.com/2012/08/09/truvada-heterosexuals-aids-hiv-prevention-pill_n_1760542.html">Heterosexual men and women</a> make up more than one-fourth of new cases of HIV, and "that's not a portion of the epidemic we want to ignore," the CDC's Dr. Dawn Smith, who was the lead author of the new recommendations, told the Associated Press. The FDA also approved a new drug this year, <a href="http://www.huffingtonpost.com/2012/08/27/stribild-hiv-treatment-fda_n_1834734.html">Stribild</a>, to treat HIV, Reuters reported.




  • 8. Engineered Stem Cells Could Play A Part In Fighting HIV


    In findings published this year in the journal <em>PLoS Pathogens</em>, scientists from the University of California, Los Angeles found that it's possible to <a href="http://www.huffingtonpost.com/2012/04/16/stem-cell-aids-hiv-study-ucla_n_1428660.html">genetically engineer stem cells</a> to attack living HIV-infected cells in mice. While the study was only for "proof-of-principle," it "lays the groundwork for the potential use of this type of an approach in combating HIV infection in infected individuals, in hopes of eradicating the virus from the body," study researcher Dr. Scott G. Kitchen, an assistant professor of medicine at UCLA, said in a statement.




  • 9. Pretty Much Everyone Should Be Screened For HIV


    People should be screened for HIV even if they're not at high risk of contracting the infection, according to draft recommendations released just last month by the U.S. Preventive Services Task Force. The recommendations would mean that everyone between the ages of 15 and 65 should be <a href="http://www.huffingtonpost.com/2012/11/19/routine-hiv-screening-us-preventive-services-task-force-uspstf_n_2161090.html">screened for HIV</a>, even if they're not at high risk for it, Reuters reported. "The prior recommendations were for screening high-risk adults and adolescents," Dr. Douglas Owens, a member of the USPSTF task force and a Stanford University medical professor, told Reuters. "The current recommendation is for <a href="http://www.huffingtonpost.com/2012/11/19/routine-hiv-screening-us-preventive-services-task-force-uspstf_n_2161090.html">screening everyone</a>, regardless of their risk."




  • 10. People Should Be Treated With Antiretrovirals As Soon As They're Diagnosed WIth HIV


    <em>All</em> HIV patients should be <a href="http://healthland.time.com/2012/07/23/new-advice-calls-for-putting-all-hiv-patients-on-drug-treatment/">treated immediately with antiretrovirals</a>, according to new guidelines issued this year from a panel of the International Antiviral Society-USA, as reported by <em>TIME</em>. The recommendations are counter to previous guidelines, which said that antiretrovirals should only be used if the CD4 count -- a measure of immune cells in a person's body -- becomes less than 350 cells for every mm3 of blood.




  • Growing Up with HIV


    During the AIDS 2012 conference, Christina Rodriguez talks about growing up with HIV.